David
Jiménez Castro
Profesor/a Titular Universidad
Brigham and Women's Hospital
Boston, Estados UnidosPublications en collaboration avec des chercheurs de Brigham and Women's Hospital (21)
2024
-
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review
Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 6, pp. 851-865
-
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications
Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 5, pp. 773-789
2023
-
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
Thrombosis Research, Vol. 222, pp. 31-39
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Cancer-Associated Thrombosis: Trends in Clinical Features, Treatment, and Outcomes From 2001 to 2020
JACC: CardioOncology, Vol. 5, Núm. 6, pp. 758-772
-
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials
Journal of the American College of Cardiology, Vol. 81, Núm. 1, pp. 16-30
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Sex-Related Differences in Patient Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study
Seminars in Thrombosis and Hemostasis, Vol. 49, Núm. 7, pp. 725-735
2022
-
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966
-
Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study
Thrombosis and Haemostasis, Vol. 123, Núm. 6, pp. 649-662
-
Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study
Thrombosis Research, Vol. 214, pp. 122-131
-
Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment
Contemporary Clinical Trials, Vol. 115
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2020
-
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Journal of the American College of Cardiology, Vol. 75, Núm. 23, pp. 2950-2973
-
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Thrombosis and Haemostasis, Vol. 120, Núm. 7, pp. 1004-1024
2019
-
Pulmonary embolism hospitalization, readmission, and mortality rates in US older adults, 1999-2015
JAMA - Journal of the American Medical Association
-
Use of Prophylaxis for Prevention of Venous Thromboembolism in Patients with Isolated Foot or Ankle Surgery: A Systematic Review and Meta-Analysis
Thrombosis and Haemostasis, Vol. 19, Núm. 10, pp. 1686-1694
2017
-
Comparison of fatal or irreversible events with extended-duration betrixaban versus standard dose enoxaparin in acutely Ill medical patients: An APEX trial substudy
Journal of the American Heart Association, Vol. 6, Núm. 7
2016
-
Extended thromboprophylaxis with betrixaban in acutely ill medical patients
New England Journal of Medicine, Vol. 375, Núm. 6, pp. 534-544
-
Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: A pooled analysis of 926 patients
Journal of Thrombosis and Haemostasis, Vol. 14, Núm. 1, pp. 105-113